{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:25:06Z","timestamp":1790727906823,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T00:00:00Z","timestamp":1345507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s12013-012-9419-1","type":"journal-article","created":{"date-parts":[[2012,8,20]],"date-time":"2012-08-20T05:11:25Z","timestamp":1345439485000},"page":"203-210","source":"Crossref","is-referenced-by-count":46,"title":["Expression and Biologic Significance of Adiponectin Receptors in Papillary Thyroid Carcinoma"],"prefix":"10.1007","volume":"65","author":[{"given":"Shih-Ping","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chiung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Ching","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Jen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,21]]},"reference":[{"key":"9419_CR1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.surg.2010.10.016","volume":"148","author":"JD Cramer","year":"2010","unstructured":"Cramer, J. D., Fu, P., Harth, K. C., Margevicius, S., & Wilhelm, S. M. (2010). Analysis of the rising incidence of thyroid cancer using the surveillance, epidemiology and end results national cancer data registry. Surgery, 148, 1147\u20131152.","journal-title":"Surgery"},{"key":"9419_CR2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008). Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet, 371, 569\u2013578.","journal-title":"Lancet"},{"key":"9419_CR3","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/ijc.24913","volume":"126","author":"MF Leitzmann","year":"2010","unstructured":"Leitzmann, M. F., Brenner, A., Moore, S. C., Koebnick, C., Park, Y., Hollenbeck, A., et al. (2010). Prospective study of body mass index, physical activity and thyroid cancer. International Journal of Cancer, 126, 2947\u20132956.","journal-title":"International Journal of Cancer"},{"key":"9419_CR4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.surg.2009.11.004","volume":"147","author":"S-P Cheng","year":"2010","unstructured":"Cheng, S.-P., Chi, C.-W., Tzen, C.-Y., Yang, T.-L., Lee, J.-J., Liu, T.-P., et al. (2010). Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery, 147, 847\u2013853.","journal-title":"Surgery"},{"key":"9419_CR5","first-page":"1721","volume":"23","author":"S-P Cheng","year":"2010","unstructured":"Cheng, S.-P., Yin, P.-H., Chang, Y.-C., Lee, C.-H., Huang, S.-Y., & Chi, C.-W. (2010). Differential roles of leptin in regulating cell migration in thyroid cancer cells. Oncology Reports, 23, 1721\u20131727.","journal-title":"Oncology Reports"},{"key":"9419_CR6","first-page":"1265","volume":"26","author":"S-P Cheng","year":"2011","unstructured":"Cheng, S.-P., Yin, P.-H., Hsu, Y.-C., Chang, Y.-C., Huang, S.-Y., Lee, J.-J., et al. (2011). Leptin enhances migration of human papillary thyroid cancer cells through the PI3K\/AKT and MEK\/ERK signaling pathways. Oncology Reports, 26, 1265\u20131271.","journal-title":"Oncology Reports"},{"key":"9419_CR7","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","volume":"270","author":"PE Scherer","year":"1995","unstructured":"Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995). A novel serum protein similar to C1q, produced exclusively in adipocytes. The Journal of Biological Chemistry, 270, 26746\u201326749.","journal-title":"The Journal of Biological Chemistry"},{"key":"9419_CR8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","volume":"257","author":"Y Arita","year":"1999","unstructured":"Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., et al. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications, 257, 79\u201383.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9419_CR9","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","volume":"423","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., et al. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423, 762\u2013769.","journal-title":"Nature"},{"key":"9419_CR10","doi-asserted-by":"crossref","first-page":"30817","DOI":"10.1074\/jbc.M402367200","volume":"279","author":"A Tsuchida","year":"2004","unstructured":"Tsuchida, A., Yamauchi, T., Ito, Y., Hada, Y., Maki, T., Takekawa, S., et al. (2004). Insulin\/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. The Journal of Biological Chemistry, 279, 30817\u201330822.","journal-title":"The Journal of Biological Chemistry"},{"key":"9419_CR11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2796.2004.01426.x","volume":"257","author":"ME Trujillo","year":"2005","unstructured":"Trujillo, M. E., & Scherer, P. E. (2005). Adiponectin\u2014Journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. Journal of Internal Medicine, 257, 167\u2013175.","journal-title":"Journal of Internal Medicine"},{"key":"9419_CR12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6603051","volume":"94","author":"I Kelesidis","year":"2006","unstructured":"Kelesidis, I., Kelesidis, T., & Mantzoros, C. S. (2006). Adiponectin and cancer: a systematic review. British Journal of Cancer, 94, 1221\u20131225.","journal-title":"British Journal of Cancer"},{"key":"9419_CR13","doi-asserted-by":"crossref","unstructured":"Dalamaga, M., Diakopoulos, K. N., & Mantzoros, C. S. (2012). The role of adiponectin in cancer: A review of current evidence. Endocrine Reviews. doi: 10.1210\/er.2011-1015 (in press).","DOI":"10.1210\/er.2011-1015"},{"key":"9419_CR14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2265.2003.01897.x","volume":"59","author":"P Iglesias","year":"2003","unstructured":"Iglesias, P., Alvarez Fidalgo, P., Codoceo, R., & Diez, J. J. (2003). Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clinical Endocrinology, 59, 621\u2013629.","journal-title":"Clinical Endocrinology"},{"key":"9419_CR15","doi-asserted-by":"crossref","first-page":"E2023","DOI":"10.1210\/jc.2010-1908","volume":"96","author":"N Mitsiades","year":"2011","unstructured":"Mitsiades, N., Pazaitou-Panayiotou, K., Aronis, K. N., Moon, H. S., Chamberland, J. P., Liu, X., et al. (2011). Circulating adiponectin is inversely associated with risk of thyroid cancer: In vivo and in vitro studies. The Journal of Clinical Endocrinology and Metabolism, 96, E2023\u2013E2028.","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"9419_CR16","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2008-1102","volume":"93","author":"RE Schweppe","year":"2008","unstructured":"Schweppe, R. E., Klopper, J. P., Korch, C., Pugazhenthi, U., Benezra, M., Knauf, J. A., et al. (2008). Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. The Journal of Clinical Endocrinology and Metabolism, 93, 4331\u20134341.","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"9419_CR17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jss.2009.05.045","volume":"164","author":"S-P Cheng","year":"2010","unstructured":"Cheng, S.-P., Lee, J.-J., Chi, C.-W., Chang, K.-M., & Chen, Y.-J. (2010). Platonin improves survival of skin allografts. Journal of Surgical Research, 164, 146\u2013154.","journal-title":"Journal of Surgical Research"},{"key":"9419_CR18","first-page":"947","volume":"104","author":"B Cady","year":"1988","unstructured":"Cady, B., & Rossi, R. (1988). An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery, 104, 947\u2013953.","journal-title":"Surgery"},{"key":"9419_CR19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.beem.2005.07.008","volume":"19","author":"A Koerner","year":"2005","unstructured":"Koerner, A., Kratzsch, J., & Kiess, W. (2005). Adipocytokines: Leptin\u2014The classical, resistin\u2014The controversial, adiponectin\u2014The promising, and more to come. Best Practice & Research Clinical Endocrinology & Metabolism, 19, 525\u2013546.","journal-title":"Best Practice & Research Clinical Endocrinology & Metabolism"},{"key":"9419_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1677\/ERC-06-0068","volume":"14","author":"L Vona-Davis","year":"2007","unstructured":"Vona-Davis, L., & Rose, D. P. (2007). Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocrine-Related Cancer, 14, 189\u2013206.","journal-title":"Endocrine-Related Cancer"},{"key":"9419_CR21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12013-009-9066-3","volume":"55","author":"J Sun","year":"2009","unstructured":"Sun, J., Xu, Y., Dai, Z., & Sun, Y. (2009). Intermittent high glucose stimulate MCP-l, IL-18, and PAI-1, but inhibit adiponectin expression and secretion in adipocytes dependent of ROS. Cell Biochemistry and Biophysics, 55, 173\u2013180.","journal-title":"Cell Biochemistry and Biophysics"},{"key":"9419_CR22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/en.2005-1030","volume":"147","author":"L Qiao","year":"2006","unstructured":"Qiao, L., Schaack, J., & Shao, J. (2006). Suppression of adiponectin gene expression by histone deacetylase inhibitor valproic acid. Endocrinology, 147, 865\u2013874.","journal-title":"Endocrinology"},{"key":"9419_CR23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/1055-9965.EPI-06-0621","volume":"16","author":"K Michalakis","year":"2007","unstructured":"Michalakis, K., Williams, C. J., Mitsiades, N., Blakeman, J., Balafouta-Tselenis, S., Giannopoulos, A., et al. (2007). Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: A case control study. Cancer Epidemiology, Biomarkers and Prevention, 16, 308\u2013313.","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"9419_CR24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000127424","volume":"73","author":"ET Petridou","year":"2007","unstructured":"Petridou, E. T., Mitsiades, N., Gialamas, S., Angelopoulos, M., Skalkidou, A., Dessypris, N., et al. (2007). Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: Two case\u2013control studies. Oncology, 73, 261\u2013269.","journal-title":"Oncology"},{"key":"9419_CR25","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/bjs.7072","volume":"97","author":"JM Howard","year":"2010","unstructured":"Howard, J. M., Beddy, P., Ennis, D., Keogan, M., Pidgeon, G. P., & Reynolds, J. V. (2010). Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. British Journal of Surgery, 97, 1020\u20131027.","journal-title":"British Journal of Surgery"},{"key":"9419_CR26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/jcp.2009.066175","volume":"62","author":"V Barresi","year":"2009","unstructured":"Barresi, V., Grosso, M., Giuffre, G., Tuccari, G., & Barresi, G. (2009). The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. Journal of Clinical Pathology, 62, 705\u2013709.","journal-title":"Journal of Clinical Pathology"},{"key":"9419_CR27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1756-9966-30-107","volume":"30","author":"T Tsukada","year":"2011","unstructured":"Tsukada, T., Fushida, S., Harada, S., Terai, S., Yagi, Y., Kinoshita, J., et al. (2011). Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer. Journal of Experimental & Clinical Cancer Research, 30, 107.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"9419_CR28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/PGP.0b013e3182469583","volume":"31","author":"N Yamauchi","year":"2012","unstructured":"Yamauchi, N., Takazawa, Y., Maeda, D., Hibiya, T., Tanaka, M., Iwabu, M., et al. (2012). Expression levels of adiponectin receptors are decreased in human endometrial adenocarcinoma tissues. International Journal of Gynecological Pathology, 31, 352\u2013357.","journal-title":"International Journal of Gynecological Pathology"},{"key":"9419_CR29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2009.12.018","volume":"117","author":"G Pfeiler","year":"2010","unstructured":"Pfeiler, G., Hudelist, G., Wulfing, P., Mattsson, B., Konigsberg, R., Kubista, E., et al. (2010). Impact of AdipoR1 expression on breast cancer development. Gynecologic Oncology, 117, 134\u2013138.","journal-title":"Gynecologic Oncology"},{"key":"9419_CR30","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1002\/ijc.25301","volume":"127","author":"JS Byeon","year":"2010","unstructured":"Byeon, J. S., Jeong, J. Y., Kim, M. J., Lee, S. M., Nam, W. H., Myung, S. J., et al. (2010). Adiponectin and adiponectin receptor in relation to colorectal cancer progression. International Journal of Cancer, 127, 2758\u20132767.","journal-title":"International Journal of Cancer"},{"key":"9419_CR31","doi-asserted-by":"crossref","first-page":"s858","DOI":"10.1093\/ajcn\/86.3.858S","volume":"86","author":"D Barb","year":"2007","unstructured":"Barb, D., Williams, C. J., Neuwirth, A. K., & Mantzoros, C. S. (2007). Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. The American Journal of Clinical Nutrition, 86, s858\u2013s866.","journal-title":"The American Journal of Clinical Nutrition"},{"key":"9419_CR32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.metabol.2010.02.006","volume":"60","author":"JT Park","year":"2011","unstructured":"Park, J. T., Yoo, T. H., Chang, T. I., Lee, D. H., Lee, J. H., Lee, J. E., et al. (2011). Insulin resistance and lower plasma adiponectin increase malignancy risk in nondiabetic continuous ambulatory peritoneal dialysis patients. Metabolism: Clinical and Experimental, 60, 121\u2013126.","journal-title":"Metabolism: Clinical and Experimental"},{"key":"9419_CR33","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.222657499","volume":"99","author":"E Tomas","year":"2002","unstructured":"Tomas, E., Tsao, T. S., Saha, A. K., Murrey, H. E., Zhang, C. C., Itani, S. I., et al. (2002). Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academy of Sciences of the United States of America, 99, 16309\u201316313.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9419_CR34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/JOE-11-0260","volume":"211","author":"HJ Choi","year":"2011","unstructured":"Choi, H. J., Kim, T. Y., Chung, N., Yim, J. H., Kim, W. G., Kim, J. A., et al. (2011). The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside. Journal of Endocrinology, 211, 79\u201385.","journal-title":"Journal of Endocrinology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-012-9419-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12013-012-9419-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-012-9419-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T14:22:20Z","timestamp":1714314140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12013-012-9419-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,21]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["9419"],"URL":"https:\/\/doi.org\/10.1007\/s12013-012-9419-1","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,21]]}}}